Moreover, Bach2 up‐regulation led to a pronounced decrease of PU.1, IRF4, and IL‐9 expression in the CD4+ T cells from SLE patients and healthy volunteers (Fig. 3D). This evidence concerns the gene IL9 and systemic lupus erythematosus.